Parnell Pharmaceuticals Holdings Ltd. Announces Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2014; Provides Revenue Guidance for Second Half of 2014 and Full Year of 2015
February 25, 2015 at 07:00 am EST
Parnell Pharmaceuticals Holdings Ltd. announced unaudited consolidated earnings results for the six months ended December 31, 2014. For the period, the company reported revenue of AUD 3,662,452 against AUD 2,843,993 a year ago. Loss before income tax was AUD 1,426,080 against AUD 4,416,483 a year ago. Loss for the year was AUD 1,428,522 or AUD 0.11 per basic and diluted share against AUD 4,416,483 or AUD 0.59 per basic and diluted share a year ago.
Increased revenues indicates strong revenue growth in the second half of 2014.
The company also believes that increased revenues in this six months period places on a solid trajectory for strong double-digit revenue growth in 2015 across all operating segments.